Nourished Natural Health Performance Manager · Aptitude Test
01 / 25
Meta Testing Engine · Diagnosis & 30-Day Plan
Rebuild the testing engine.
The structure is sound. But we fund losers by default, burn winners out in weeks, and promote them before they’ve earned it. Here’s the evidence — and the first 30 days that fix it.
A$7,624
Live testing spend · last 30d
0.26×
Testing ROAS
93%
Spent on decided losers
1 of 14
Ads above break-even (30d)
Nourished Natural Health · prepared for the FounderMeta Marketing API · act_214033572315014 · AUD · 7d-click/1d-view
The Approach
Account Diagnosis & Campaign Prioritisation
The account has strong bones. This report lines it up against the 2026 best-practice playbook today’s leading eCommerce media buyers run — and prioritises the three changes that close the gap.
01
ABO → CBO
Let Meta allocate — stop funding every ad set regardless of return.
02
Feed the machine
Constant creative volume and angle diversity — never one fatiguing winner.
03
Promote on evidence
A minimum-signal bar before any duplication to scale.
Grounded in what these operators are teaching & running at scale
01 · Wasted spend
ABO funds losers on purpose
Under ad-set budget optimization, every ad set gets its own budget and spends it — converting or not. Last 30 days in the live ABO | Testing campaign, most of it went to ad sets already proven to lose.
▣
SHOT 1
Ad Sets view · ABO | Testing · Last 30 days · sorted by Results. The nine ad sets showing “—” spent real budget for zero purchases or subscribes.
Drop shot-1.png into img/ — it appears here automatically.
93%
of 30-day test spend went to sub-0.5× ad sets
A$7,086
burned on ad sets Meta already knew were losing
9
ad sets with spend and no purchase or subscribe result
Why CBO fixes it. One budget at the campaign; Meta routes it in real time toward the ad sets most likely to convert. The A$300–430 cheques to 0-purchase ad sets simply stop.
02 · Creative fatigue
Winners fatigue in weeks — and we fund the decline
A winner doesn’t stay a winner. Meta finds the buyers who resonate fast; at a fixed budget it exhausts that pocket and ROAS decays. v43.3 — “The Secret That Reduced Unwanted PCOS” peaked at 1.29× in early May, then slid to 0.13× — while spend kept flowing.
Weekly spendROASBreak-even 1.0×
CON02A — “Tweezer Tax” shows the same shape: a 1.38× first week on 2 purchases, then a long, expensive tail below break-even once real budget arrived.
02 · The antidote
If winners decay, throughput is the only edge
The durable answer to fatigue is a steady supply of fresh creative and new angles. Our output moved the wrong way as returns fell — 121 new ads in May down to 63 in June — right as ROAS dropped below 0.35×.
New ads created / monthAccount ROASDirectional — correlation, not proof of cause.
03 · From testing to scale
CBO testing + creative volume & diversity gives us winners ready to scale
Today we crown a “winner” on a thin signal, then it collapses when the budget lands. CON02A — Tweezer Tax looked like a 1.27× winner on 4 purchases — then bled A$2,174 at 0.19× once promoted to the winners campaign. Real winners sit top-left: strong ROAS on validated spend. Volume + diversity under CBO makes more of them — and only those earn the scale.
Validated winner (ROAS ≥ 1)Promoted → tanked at scaleBreak-even
▣
SHOT 2
The same CON02A — Tweezer Tax creative promoted into the winners campaign: A$2,174 at 0.19× — it never reproduced its test number at scale.
Drop shot-2.png into img/ — it appears here automatically.
The bar that makes scaling safe. Only promote once a creative clears a real sample — e.g. ≥15 purchases and ≥3 days at or above target ROAS in CBO testing. Then scale holds instead of collapsing.
04 · The 30-day plan
Three priorities
Priority 1
Restructure testing → CBO
Consolidate ABO test ad sets into CBO. One budget, Meta allocates. Kill the per-ad-set floor.
Reclaim ≈A$7,086/30d now spent on sub-0.5× ad sets.
Priority 2
Fund the creative engine
A weekly quota of net-new concepts and distinct angles — volume plus variety.
Rebuild throughput above the May pace (~120/mo) with real angle diversity.
Priority 3
Competitive Scaling Environment
No duplication without ≥15 purchases and ≥3 days ≥ target CPA in testing.
Stop pouring A$10k+ into already-peaked creatives.
05 · Targets
The two business metrics we’ll move — and how
Every change in the plan ladders up to two numbers: more diverse creative going in, and a lower cost to acquire coming out. Both are downstream of CBO testing plus a real promotion bar.
How — a weekly quota of net-new concepts and angles; CBO testing surfaces more validated winners to rotate in, so no single creative carries the account.
CPA
▼ reduce
A$249now · last 30d (was A$151 in April)
→
A$115target · internal business target
How — CBO starves the 0-purchase ad sets (reclaim ≈A$7,086/30d); the promotion bar (≥15 purchases, ≥ target CPA) stops overspend on already-peaked winners.
The through-line. Diversity feeds the funnel with fresh, efficient creative; the CPA discipline stops budget leaking into fatigue. Move both and ROAS follows.
Task 2: Creative Strategy and Direct-Response Instincts
▣
PRODUCT
AndroEase Plus — the product in focus.
Drop androease-plus.jpg into img/.
Section A
A
Customer & Creative Insights
What the research says — grounded in evidence wherever possible. Starting with the three insights that should drive the advertising.
A · Insight 1 of 3
She's not shopping for a supplement. She wants to feel understood.
The ads that name her secret daily reality out-earn the ones that pitch the product. The creative's first job is recognition, not persuasion.
The proof · account data
Understand-her angles3.9%
Product-led ads2.6%
CTR by creative family · account avg 3.1% · 2.2× the click-to-purchase rate. Meta account, Jun–Jul 2026.
"the hair on my face is like a constant slap reminder of my lack of 'girlyness'."
Price is a real barrier. But discounting is a crutch, not a cure.
The account only clears break-even at 50% off — she genuinely feels the price. The durable fix is results, social proof and trust, so value clears the price without a half-off crutch.
1.24×
ROAS on 50%-off ads — the only profitable segment
0.86×
ROAS on every other ad
Value ÷ spend · Meta account, Jun–Jul 2026. The discount converts but erodes margin — trust is what lets us stop leaning on it.
"Have no idea how much money has been spent so far... We are under debt due to such expensive treatment."
Cost-fatigue VOC + a 5-star results testimonial (social proof).
img/voc-i3.png
A · Top Objections
Top objections preventing purchase
Three, ranked most-blocking first. They resolve into two families — does it work? and how long until I know? — and price is not a third; price is the instrument that answers the second.
1
"How can a pill I swallow change hair on my face — and why would it, when nothing else has?"
Two questions, one blocker. The first is comprehension, not trust: she can believe every claim and still not buy, because she has no model for how a capsule reaches a follicle. The second is the loudest objection in the research — a decade of failed supplements, and each failure re-evidencing that she's unfixable. Every other proof asset sits downstream of both.
Counter: draw the chain — insulin → androgens → DHT at the follicle → fine hair switches to coarse — then the dose that presses each step. Differentiate on dose and form, not promise size: transparent per-ingredient dosing, no proprietary blends, and the spearmint teardown (the category cites a brewed-tea study to sell capsules that aren't tea).
Account data: the founder ad opening "Your labs look normal." (i08.3) is the account's #2 spender at $1,658, beats blended ROAS (1.13 vs 0.95) and pulls a $156 AOV against a $55 account average — the client's own structure files it under "Static Winners."
2
"What if it makes it worse?"
Asymmetric loss. For a woman whose private fear is I'm becoming a man, "may raise androgens" isn't a side effect — it's the catastrophic outcome, aimed at the exact thing she already fears. And it's silent: she reads the thread, closes the tab, never tells you.
Counter: name it before she Googles it. A formula reviewed by a naturopathic doctor, every dose printed on the label, and a mechanism she can follow — the unknown is what makes the fear load-bearing.
"Months of waiting — for every other day instead of every day. And another thing that costs money."
Time and money are the same objection wearing two hats. Six weeks minimum, three months for the real picture, and the honest result is a frequency reduction rather than an ending — survivable separately, but stacked on a cost wound they exceed the patience budget of a buyer who's been let down before. Note what the account data says, though: this isn't price sensitivity. The 50%-off campaigns carry a higher AOV than full price ($91 vs $85), because the discount is a multi-month tier, not a cheaper bottle.
Counter: sell it as a commitment offer, not a discount — three months at once, so she buys enough runway to reach the point where it works. The 101-Day Results Commitment is built to outlast exactly this — make the slowness the reason the guarantee runs that long, not something to apologise for. Honest timelines beat fast promises with this buyer.
Account data: 50%-off ROAS 1.245 vs 0.858 everywhere else — the only profitable segment, and the reason the fix is trust rather than a deeper cut.
Two families, one instrument: mechanism answers does it work · the 3-month offer answers how long.Sources: Research/reddit-voc.md · proof-library.md · offer-brief.md · act_214033572315014 (Jun 1–Jul 18 2026)
A · Strongest Motivations
Strongest emotional motivations to buy
The drivers that actually move her to act — each backed by in-the-wild voice-of-customer, and tagged with the buying agenda it fires. Sequence matters: mechanism is the permission structure that makes the femininity payoff credible enough to hope for.
1
To feel like a woman again — and stop hiding
The Lover
One motivation, two halves. She is not buying smoother skin — she is buying back her category membership as a woman; visible androgen symptoms read as attacks on identity, not cosmetic annoyances. And the price she actually pays isn't the hair, it's the life she cancels around it: the window seat, the deleted selfie, the plan she wanted to go to.
So sell the payoff in situations, not adjectives — daylight, up close, a photo she kept — and agitate the hiding, never her appearance. Naming the behaviour makes her feel known; naming the face makes her feel caught.
Payoff already on the review wall: "AndroEase has really helped me feel more feminine!" — Emily D. · "It has made me feel confident again. No more hiding." — Linda I.
2
Hope that ONE thing finally works — at the root
The Doctor
The market's organising worldview: root cause over symptom suppression. This is the highest-scoring agenda across every segment file, and it's what converts a woman who has stopped believing promises.
Vindication — being dismissed with "just lose weight"
The Warrior
The shared category enemy. An ad that takes it seriously is doing something her doctor didn't — which is why the founder ad opening "Your labs look normal" is the account's #2 spender at $1,658, beats blended ROAS (1.13 vs 0.95) and pulls a $156 AOV against a $55 account average.
On the agenda labels. The Lover / Doctor / Warrior / Mourner / Protector / Nurturer / Jester set isn't brand-archetype language — it's the seven primary emotional systems from affective neuroscience (SEEKING, RAGE, FEAR, LUST, CARE, PANIC/GRIEF, PLAY), mapped 1:1 onto buyer stances. Source: Jaak Panksepp, Affective Neuroscience: The Foundations of Human and Animal Emotions (Oxford University Press, 1998); accessible companion, Panksepp & Biven, The Archaeology of Mind (W. W. Norton, 2012). These are pre-cognitive command systems mapped by brain stimulation and lesion studies across mammals — which is why we treat them as drives she doesn't choose, rather than personality types. Not to be confused with the 12 Jungian brand archetypes (Mark & Pearson), which describe the brand's personality, not the buyer's stance.
Unowned territory: the depression floor is the biggest blindspot in the VOC — all three motivations face upward. Post-pill regret is real but narrower; it's a segment-gated hook, not a top-three driver.Sources: Research/reddit-voc.md · seg-2-the-hiding.md §9 · market-brief.md §2 · methodology/persuasion-stack-provenance.md
Section B
B
Creative Strategy — Three Concepts
Three distinct concepts for AndroEase Plus — meaningfully different, not variations of one idea.
Concept 1 · Recognition
The Silent Checklist
The symptoms she hides, ticked off and named as one hormonal pattern.
Concept 2 · Insight story
A Tale of Two Women
Same PCOS, same chin hair — two responses, one year apart.
Concept 3 · Founder
The Founder's Confession
Tamika — the nutritionist who shaved her own face for a decade.
B — Concept 1
Concept 1
The Silent Checklist
Recognition · static / UGC
Target audience
Problem-aware women 25–40 with scattered PCOS/androgen symptoms — chin & jaw hair, hormonal acne, thinning, irregular cycles — who haven't linked them to one root. Insulin-Resistant & undiagnosed.
Customer insight
She wants to feel understood. She's never seen her exact symptoms named as one thing, so recognition earns the click before any pitch.
Core creative angle
A checklist as a mirror. Each item is a private concealment ritual — "shave before the video call," "pluck the chin daily," "dodge the daylight selfie." The turn: these aren't separate flaws, they're one androgen signal.
Primary hook
"Tick the ones you do before anyone sees you."
Key message
Your scattered symptoms are one hormonal pattern, treatable at the root. Not five separate things wrong with you.
Why it can perform
Recognition / annotation ads are the account's top-CTR family — 3.9% vs 2.6%. High-salience and thumb-stopping, cheap to produce and variant-test, and it makes her feel seen before it sells.
B — Concept 2
Concept 2
A Tale of Two Women
Insight-led story · split-path video
Target audience
Solution-aware women who've tried the surface fixes — laser, waxing, creams, the pill — and are worn down that the symptoms keep coming back.
Customer insight
Root-cause vs surface is the belief that unlocks the sale. You can't tweeze away a hormone imbalance.
Core creative angle
Two women, same PCOS, same chin hair. Woman A keeps fighting what's visible — the tweezer drawer, the laser bills, the pre-call shave. Woman B supports the androgen signal underneath. Their year diverges.
Primary hook
"Two women. Same PCOS. Same chin hair. A year later, only one is still hiding."
Key message
Keep managing the surface forever, or address the hormone underneath. Only one path ends.
Why it can perform
Story / journey creatives convert 2.2× better after the click. It dramatizes the highest-leverage belief (root-cause) and pre-empts "why is this different from what I already tried." Emotional and shareable.
B — Concept 3
Concept 3
The Founder's Confession
Founder story · voice-memo UGC
Target audience
Skeptical, burned buyers who distrust supplement brands and have been dismissed by doctors — they need a credible human on their side.
Customer insight
Proof and trust must always be established. She trusts a credentialed fellow-sufferer over a faceless brand.
Core creative angle
Tamika, to camera. The decade she spent dismissed, what she learned as a clinical nutritionist, and why she formulated AndroEase for herself first — clinician-reviewed, transparent doses, no proprietary blends.
Primary hook
"I'm a nutritionist. For 10 years I shaved my face before anyone woke up."
Key message
This wasn't made by a supplement company. It was made by a woman with your exact symptoms who had the training to fix them.
Why it can perform
The account's "Voice Memo" founder-story creative is a top performer — 7.4% CTR, 150+ purchases. Founder authenticity answers the trust objection head-on and is hard for a competitor to copy.
Section C
C
Creative Brief — Strongest Concept
Production-ready — detailed enough to hand straight to a creator or video editor without significant clarification.
Selected concept
Which of the three, and one line on why it's the strongest bet.
